Videos

Jermaine Gray, MD, provides some essential tips for various cases of vulvovaginal conditions that present in the emergency department, which was recently presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting.

Angela Dempsey, MD, MPH, gives her insights on how to advocate for your patients in post-Roe America, which was presented during her session at the recent 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.

Experts outline their clinical approach to identifying treatment failure in patients on initial pharmacologic treatment for OAB and strategies for subsequent treatment selection.

A comprehensive discussion on clinical factors that impact pharmacologic treatment selection in patients with OAB.

Panelists introduce the available treatment modalities for OAB, including behavioral modification, pharmacologic treatment, neuromodulation, and surgical approaches.

Timothy Hand, PhD, associate professor of pediatrics and immunology at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh, discusses how antibodies provided from breast milk can improve immunity in infants.

A brief overview of how and when providers incorporate urodynamic testing as part of the diagnostic workup for OAB.

Panelists further expand on the typical clinical characteristics of patients with OAB who they see in their practice, common signs and symptoms, and potential differential diagnoses.

Experts begin their panel discussion on OAB by describing the typical diagnostic process and initial conversations that they have with patients suspected of having the condition.

Urologist Benjamin Brucker, MD, urogynecologist Eman Elkadry, MD, and nurse practitioner Jenna Horton, NP introduce themselves, outline their credentials, and briefly describe the patients with overactive bladder (OAB) who they typically see in their clinical practice.

Hugh Taylor, MD, discusses topic which will be presented at the 4th Annual International Congress on the Future of Women’s Health.

Lori Homa, MD, discusses the opening of a new fertility clinic from Allegheny Health Network.

Monica Christmas, MD, associate professor at the University of Chicago, discusses the findings of a study on how vaginal estrogen may be used to treat urinary symptoms in postmenopausal women, along with how she hopes these findings will impact treatment in women with urinary symptoms.

Emre Seli, MD, chief scientific officer of the March of Dimes, discusses the organization's initiative to research recurrent pregnancy loss.

Sadia Haider, MD, MPH, talks about the latest guidelines from the Society of Family Planning regarding contraception for trans patients, RH testing during pregnancy, and Depo-Provera self-administration at the 2023 ACOG Annual Clinical and Scientific Meeting.

In this video interview, experts provide a synopsis of their presentation about technology and obstetric care at the 2023 ACOG Annual Clinical and Scientific Meeting.

At the 2023 ACOG Annual Clinical and Scientific Meeting, Haywood Brown, MD, discusses the current maternal mortality rate in the United States, as well as disparities affecting different racial and ethnic groups.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Caitlin Martin, MD, discussed the concerning rise in substance use mortalities and maternal mortalities.

Anne Banfield, MD, discusses the highlights from her presentation on primary HPV screening at the 2023 ACOG Annual Clinical and Scientific Meeting in Baltimore, Maryland.

At the 2023 ACOG Annual Clinical & Scientific Meeting, Gloria Richard-Davis MD, MBA, NCMP, FACOG, discussed the importance of using hormone therapies to treat menopause symptoms.

Genevieve Neal-Perry, MD, PhD, talks about the recent approval of fezolinetant (Veozah; Astellas Pharma) and her latest phase 3 research presented at the 2023 ACOG Annual Clinical and Scientific Meeting.

The FDA Advisory Committee recently voted in support of approval for Pfizer's maternal immunization vaccine to help prevent RSV in infants. In this Contemporary Pediatrics® interview, Tina Tan, MD, FAAP, FIDSA, FPIDS, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital, Chicago, explains what this means for this patient population ahead of an expected FDA decision in August, 2023.

Beth Garner, MD, MPH, chief scientific officer, Ferring Pharmaceuticals, talks the current state of fertility in the United States.

Lauren Pace, MD, obstetrician-gynecologist at the University of Alabama at Birmingham, discusses how pain levels are perceived differently in patients receiving an abortion based on race.

Erica Gunderson, PhD, MS, MPH, RD, senior research scientist, Kaiser Permanente Northern California Division of Research, and professor of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine discusses what it means to be the recipient of the 2022-2023 March of Dimes Agnes Higgins Award, and her lifetime research linking breastfeeding and future maternal cardiometabolic health.

Jonathan Miller, MD, pediatrician and chief of primary care, pediatrics, at Nemours Children's Health in the Delaware Valley, spoke about the latest data regarding early HPV vaccination in children as young as 9 at the 2023 Pediatric Academic Societies meeting.

In part 3 of our series on abortion, Katrina Heyrana, MD, discusses whether mifepristone will remain available for use in the United States.

Kate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.

Drs Kate White and Harold Bays share their approach to initiating conversations with patients on contraception options and suggest which practitioners might be best suited to these conversations.